Amneal Pharmaceuticals, Inc. Class A Common Stock - gráfico, preços e notícias (NASDAQ:AMRX)

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Trimestral Ano

Market Capitalization 42.02 M
Employee 8 500
Founded 2002
CEO Chintu PatelChirag Patel
Website www.amneal.com
Headquarter N/A
FIGI BBG00462PGG0
Industry Fabricantes de medicamentos - especializados e genéricos

Receita total

Lucro líquido

Lucro básico por ação

Dívida total

Fluxo de caixa livre

Caixa e equivalentes de caixa

Índice preço/lucro

57.27

Índice preço/fluxo de caixa

1.36

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

AMRX

Financials

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Notícias

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term

3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)

Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?

Teva’s CNS Portfolio Is Growing, But Valuation Is Stretched (NYSE:TEVA)

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

Do Options Traders Know Something About Amneal Stock We Don't?

Amneal Pharma supera projeções de LPA no 1º tri de 2026

Amneal adquire Kashiv por US$ 750 milhões e se torna líder em biossimilares

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High?

Amneal Pharmaceuticals (AMRX) is a Top-Ranked Momentum Stock: Should You Buy?